Search Site

TAQA Q1 net income $571m

Net income fell $2.58bn due to one-off items recognized in 2023.

QatarEnergy buys stake in Egypt blocks

It did not disclose the cost of the agreement.

TSMC’s April revenue up 60%

It capitalized on huge wave of demand for chips used in AI hardware.

Etihad reports record Q1 profit

Total revenue increased by $269 million in the same period.

Aramco Q1 profit down 14.5%

Despite lower profit, it will pay $31bn in dividends to Saudi government.

SFDA, SBA partner to create media content on health, food

The Saudi Food and Drug Authority and the Saudi Broadcasting Authority partner to create media content on health and food.
  • The agreement aims to create joint media sponsorship opportunities that serve both sides and to establish specialized media publications
  • The areas of cooperation include educating consumers on the safe use of cosmetic products, making television programs and providing visual and audio content

The Saudi Food and Drug Authority (SFDA) and the Saudi Broadcasting Authority (SBA) signed on Wednesday a memorandum of cooperation (MoC) to create and publish specialized and professional media content on health and food.

The MOC was signed by SFDA’s CEO, Dr. Hisham bin Saad Aljadhey, and the CEO of SBA, Mohammad bin Fahad Al-Harthi.

The MoC aims to create joint media sponsorship opportunities that serve both sides, and to establish specialized media publications, in addition to covering, transferring and managing events, media centers and local SFDA events.

The MoC includes holding joint training programs to develop human resources in related fields, exchanging experiences, transferring knowledge, and benefiting from the facilities of both sides to create television programs and visual productions.

The areas of cooperation include educating consumers on the safe use of cosmetic products, making television programs and providing visual and audio content such as podcasts, educational clips between program times regarding nutrition and public health. 

A mechanism will also be put in place to not publish any advertisements for pharmaceutical companies, food or medical devices and products until verifying that they have obtained prior approval to advertise their products.